Skip to Main Content

Author Details

Paul A Northcott
St Jude Children's Research Hospital
2006
187
79
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36548930Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.J Clin Oncol2023
37725078Lmx1a is a master regulator of the cortical hem.Elife2023
37693484PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.bioRxiv2023
36548930Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.J Clin Oncol2023
37693484PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.bioRxiv2023
37725078Lmx1a is a master regulator of the cortical hem.Elife2023
34894262Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.Neuro Oncol2022
35463474Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients.STAR Protoc2022
35709750Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.Mol Cancer Ther2022
35701672Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.Nat Genet2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
35618754Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2022
36131015Unified rhombic lip origins of group 3 and group 4 medulloblastoma.Nature2022
35982322Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.Acta Neuropathol2022
36052493Pursuing FOXR2-Driven Oncogenesis.Cancer Res2022
34894262Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.Neuro Oncol2022
34935967Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).Neuro Oncol2022
34934181Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.Lab Invest2022
35709750Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.Mol Cancer Ther2022
35701672Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.Nat Genet2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
35463474Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients.STAR Protoc2022
35618754Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2022
36131015Unified rhombic lip origins of group 3 and group 4 medulloblastoma.Nature2022
35982322Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.Acta Neuropathol2022
36052493Pursuing FOXR2-Driven Oncogenesis.Cancer Res2022
34935967Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).Neuro Oncol2022
34934181Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.Lab Invest2022
33272592Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.Trends Genet2021
34292305Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol2021
34110925Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.J Clin Oncol2021
34215733Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.Nat Commun2021
34192534Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.Cell Rep2021
33502920Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.J Clin Oncol2021
33976373Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.Commun Biol2021
34320362Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.Cell Rep2021
33272592Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.Trends Genet2021
33405951Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol2021
34409497Subgroup and subtype-specific outcomes in adult medulloblastoma.Acta Neuropathol2021
34678152Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.Cancer Cell2021
34647023A genetic mouse model with postnatal <i>Nf1</i> and <i>p53</i> loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.Neurooncol Adv2021
33502920Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.J Clin Oncol2021
34647023A genetic mouse model with postnatal <i>Nf1</i> and <i>p53</i> loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.Neurooncol Adv2021
34409497Subgroup and subtype-specific outcomes in adult medulloblastoma.Acta Neuropathol2021
34678152Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.Cancer Cell2021
34215733Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.Nat Commun2021
34320362Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.Cell Rep2021
34292305Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol2021
33976373Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.Commun Biol2021
34192534Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.Cell Rep2021
  • 1 - 50 of 374

Recommended Authors

Universidad de Oviedo
Career Start Year 2019
Number of shared co-authors 51
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2018
Number of shared co-authors 49
McGill University
Career Start Year 2017
Number of shared co-authors 26
Children's Hospital of Philadelphia
Career Start Year 2017
Number of shared co-authors 19
College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 8
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Career Start Year 2016
Number of shared co-authors 9
Children's Hospital of Philadelphia
Career Start Year 2016
Number of shared co-authors 34
The Hospital for Sick Children, University of Toronto
Career Start Year 2014
Number of shared co-authors 60
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 21
Children's Hospital Los Angeles
Career Start Year 2014
Number of shared co-authors 26
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 24
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 19
Hospital for Sick Children
Career Start Year 2011
Number of shared co-authors 21
University of California san francisco
Career Start Year 2010
Number of shared co-authors 27
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 50
National Cancer Institute
Career Start Year 2009
Number of shared co-authors 25
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 28
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 52
University of Manitoba
Career Start Year 2007
Number of shared co-authors 65
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 36
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 49
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 22
University of Manitoba
Career Start Year 2001
Number of shared co-authors 65
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 33
Hasbro Children's Hospital, Brown University.
Career Start Year 1997
Number of shared co-authors 62
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 35
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 44
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 38
University of California san francisco
Career Start Year 1991
Number of shared co-authors 51
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 72

Collaborators

The Hospital for Sick Children
Co-authored papers 108
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 96
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 69
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 68
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 54
German Cancer Research Center (DKFZ)
Co-authored papers 48
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 45
St. Jude Children's Research Hospital
Co-authored papers 37
Hospital for Sick Children
Co-authored papers 32
The Hospital for Sick Children
Co-authored papers 32
St. Jude Children's Research Hospital
Co-authored papers 31
Hospital for Sick Children
Co-authored papers 31
Dana-Farber Cancer Institute
Co-authored papers 29
N.N. Burdenko Neurosurgical Institute
Co-authored papers 26
University Medical Center Hamburg-Eppendorf
Co-authored papers 25
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 25
The Hospital for Sick Children
Co-authored papers 24
St. Jude Children's Research Hospital
Co-authored papers 24
University of Texas MD Anderson Cancer Center Houston
Co-authored papers 24
Harvard Medical School
Co-authored papers 24
Co-authored papers 24
St. Jude Children's Research Hospital
Co-authored papers 22
University of California san francisco
Co-authored papers 21
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 21
St Jude Children's Research Hospital
Co-authored papers 20
Co-authored papers 20
St. Jude Children's Research Hospital
Co-authored papers 20
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 19
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 18
Co-authored papers 18